Iroko Pharmaceuticals is a specialty pharmaceutical company founded to acquire, develop and maximize the potential of currently marketed pharmaceutical products.
Our Current Products available in the U.S.:
- Indocin® (indomethacin) suppositories and oral suspension are indicated for use in a variety of conditions, including moderate to severe rheumatoid arthritis, moderate to severe osteoarthritis and acute bursitis and/or tendonitis of the shoulder. Please see full U.S. prescribing information.
Patient Assistance Program:
For Iroko Patient Assistance Program information, please contact patientassistance@iroko.com
Medical Information:
For Medical Information, please contact IrokoInfo@ICSconnect.com
Safety/Adverse Event Reporting:
To report an adverse event, please contact IrokoInfo@ICSconnect.com or fax a report to +1-267-546-3219. You may also call +1-877-757-0676, for Medical Information requests or to report an adverse event.